CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8 T Cells.
Immunity
View this publicationImmunity
View this publicationThe Journal of investigative dermatology
View this publicationZeitschrift fur Orthopadie und Unfallchirurgie
View this publicationBiological chemistry
View this publicationCells
View this publicationJournal of fungi (Basel, Switzerland)
View this publicationLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
View this publicationEuropean heart journal
View this publicationJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
View this publicationFrontiers in immunology
View this publication